• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酸氯倍他索——何处、何时、为何?

Clobetasol propionate--where, when, why?

作者信息

Pels Ragna, Sterry Wolfram, Lademann Jürgen

机构信息

Department of Dermatology, Polikum Friedenau, Berlin, Germany.

出版信息

Drugs Today (Barc). 2008 Jul;44(7):547-57. doi: 10.1358/dot.2008.44.7.1122221.

DOI:10.1358/dot.2008.44.7.1122221
PMID:18806904
Abstract

Clobetasol propionate is the most potent of all topical steroids. It is successfully applied in the treatment of various skin diseases such as atopic dermatitis, psoriasis and vulvar lichen sclerosus. The therapy is, however, mainly symptomatic. A preventive effect is only reported in the treatment of the latter. Clobetasol propionate exerts antiinflammatory, immunosuppressive and antimitotic effects influencing the growth, differentiation and function of various cells and inhibiting cytokine production. Seven different dosage forms are available to deliver the drug to the living cells of the skin. Their choice might additionally affect patient compliance. The potency of clobetasol propionate, however, is accompanied by local and systemic side effects, such as skin atrophy and hypothalamic-pituitary-adrenal axis suppression. Patients applying clobetasol propionate must be well instructed in how to use it. Physicians prescribing clobetasol propionate should consider a diversity of factors and be able to answer the questions where, when and why.

摘要

丙酸氯倍他索是所有外用类固醇中效力最强的。它成功应用于治疗各种皮肤病,如特应性皮炎、银屑病和外阴硬化性苔藓。然而,该疗法主要是对症治疗。仅在治疗后者时报道有预防作用。丙酸氯倍他索具有抗炎、免疫抑制和抗有丝分裂作用,可影响各种细胞的生长、分化和功能,并抑制细胞因子的产生。有七种不同剂型可将药物递送至皮肤活细胞。剂型的选择可能还会影响患者的依从性。然而,丙酸氯倍他索的效力伴随着局部和全身副作用,如皮肤萎缩和下丘脑 - 垂体 - 肾上腺轴抑制。使用丙酸氯倍他索的患者必须得到关于如何使用它的充分指导。开具丙酸氯倍他索处方的医生应考虑多种因素,并能够回答在何处、何时以及为何使用的问题。

相似文献

1
Clobetasol propionate--where, when, why?丙酸氯倍他索——何处、何时、为何?
Drugs Today (Barc). 2008 Jul;44(7):547-57. doi: 10.1358/dot.2008.44.7.1122221.
2
Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.丙酸氯倍他索乳剂配方泡沫0.05%:成人和青少年类固醇反应性皮肤病的II期开放标签和III期随机对照试验综述
J Am Acad Dermatol. 2008 Sep;59(3):448-54, 454.e1. doi: 10.1016/j.jaad.2008.04.020. Epub 2008 Jun 9.
3
Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.0.05%丙酸氯倍他索喷雾剂用于治疗中度至重度斑块状银屑病。
Cutis. 2012 Feb;89(2):89-94.
4
A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.一项评估 0.05%丙酸氯倍他索与 0.1%他克莫司乳膏治疗外阴硬化性苔藓患者的双盲、随机前瞻性研究。
J Am Acad Dermatol. 2014 Jul;71(1):84-91. doi: 10.1016/j.jaad.2014.02.019. Epub 2014 Apr 3.
5
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.在中度至非常严重的斑块状银屑病患者中,丙酸氯倍他索喷雾剂0.05%作为生物治疗稳定方案的附加治疗。
Cutis. 2009 Oct;84(4 Suppl):25-32.
6
Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.0.05%丙酸氯倍他索洗发水的短期安全性评估:头皮银屑病患者的下丘脑-垂体-肾上腺轴抑制、萎缩性及眼部安全性
J Drugs Dermatol. 2006 Apr;5(4):328-32.
7
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.丙酸氯倍他索喷雾剂治疗斑块状银屑病的疗效和安全性评估。
Cutis. 2006 Nov;78(5):348-54.
8
Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.丙酸氯倍他索洗剂治疗中度至重度斑块型银屑病。
Cutis. 2004 Sep;74(3):201-6.
9
Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses.丙酸氯倍他索润肤配方泡沫剂治疗皮质类固醇反应性皮肤病。
Expert Opin Pharmacother. 2008 Aug;9(11):2001-7. doi: 10.1517/14656566.9.11.2001.
10
Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.外用黄体酮与外用丙酸氯倍他索治疗外阴硬化性苔藓患者的疗效——一项双盲随机II期试点研究。
Eur J Obstet Gynecol Reprod Biol. 2022 May;272:88-95. doi: 10.1016/j.ejogrb.2022.03.020. Epub 2022 Mar 10.

引用本文的文献

1
Irritant Contact Dermatitis Induced by Compound Clobetasol Propionate in a Patient with Undiagnosed Type 2 Diabetes Mellitus.丙酸氯倍他索诱发未确诊2型糖尿病患者的刺激性接触性皮炎
Clin Cosmet Investig Dermatol. 2025 Aug 28;18:2035-2037. doi: 10.2147/CCID.S544591. eCollection 2025.
2
Poly(lactic Acid) Fibers for Sustained Drug Delivery: Insights into Release Profiles and Cellular Interactions.用于持续药物递送的聚乳酸纤维:对释放曲线和细胞相互作用的见解
Materials (Basel). 2025 May 27;18(11):2532. doi: 10.3390/ma18112532.
3
Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.
咪喹莫特诱导的银屑病大鼠模型中氯倍他索和他克莫司治疗的评价。
Int J Mol Sci. 2024 Aug 26;25(17):9254. doi: 10.3390/ijms25179254.
4
Different Treatment Modalities of Oral Lichen Planus-A Narrative Review.口腔扁平苔藓的不同治疗方式——一篇叙述性综述
Dent J (Basel). 2023 Jan 12;11(1):26. doi: 10.3390/dj11010026.
5
Topical glucocorticoid application causing iatrogenic Cushing's syndrome followed by secondary adrenal insufficiency in infants: two case reports.局部糖皮质激素应用导致婴儿医源性库欣综合征继发自发性肾上腺功能不全:两例病例报告。
J Med Case Rep. 2022 Dec 8;16(1):455. doi: 10.1186/s13256-022-03659-2.
6
Novel Dermal Delivery Cargos of Clobetasol Propionate: An Update.丙酸氯倍他索新型皮肤给药载体:最新进展
Pharmaceutics. 2022 Feb 9;14(2):383. doi: 10.3390/pharmaceutics14020383.
7
Topical corticosteroid-induced skin atrophy: a comprehensive review.外用糖皮质激素引起的皮肤萎缩:综述
Drug Saf. 2015 May;38(5):493-509. doi: 10.1007/s40264-015-0287-7.
8
Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.因局部皮质类固醇应用引起的外源性库欣综合征:病例报告及文献复习。
Endocrine. 2010 Dec;38(3):328-34. doi: 10.1007/s12020-010-9393-6. Epub 2010 Oct 23.